Pigmentation traits are known risk factors for skin cancer. now, three new studies provide insights into the genetic factors underlying these effects, and the results reveal a surprisingly complex picture of the relationship between pigmentation traits and disease risk.
Cutaneous melanoma (CM) tends to cluster in families, with a twofold increase in disease risk in those with an affected firstdegree relative. The risk associated with an affected second-degree relative is smaller, consistent with a genetic component to disease susceptibility. As with other cancers, linkage studies in multi-case, multi-generation families were successful in identifying a small number of highly penetrant loci, including CDKN2A, ARF, CDK4 and 1p22. However, these loci explain only a small proportion of the excess familial risk, and it seems likely that multiple loci of lower penetrance will account for most of the remainder. Candidate gene association studies for common, low-penetrance risk alleles have been largely unsuccessful, and until recently, the only validated low-penetrance risk alleles for melanoma were variants in the melanocortin receptor gene, MC1R. The advent of large-scale, genome-wide association studies (GWAS) has resulted in the identification of many susceptibility loci for biological and disease phenotypes (reviewed in refs. 1 and 2). Now, two papers on pages 835 and 838 of this issue show that CM and basal cell carcinoma (BCC) can be added to this rapidly growing list 3, 4 . In one of these studies, the variants tested for association with CM and BCC were initially identified as determinants of hair, eye and skin pigmentation in Europeans, as described in a related paper 5 on page 886 and in an earlier study by the same group 6 .
Pigmentation and skin cancer
Brown and colleagues carried out a primary, two-stage GWAS of CM using samples from two Australian case-control studies 4 . A notable feature of the study design was the use of DNA pooling for the first stage, an unusual approach vindicated by the excess of associations detected at a significance threshold of P < 10 −3 compared to the number expected. The first and fourth strongest associations were seen for two SNPs at 20q11. These lie in a genomic region with extensive long-range linkage disequilibrium that contains multiple genes, including ASIP, a previously investigated candidate gene for CM. To refine the association signal, they carried out limited fine mapping of the region by genotyping 31 additional SNPs in over 2,000 cases and 2,000 controls, including those used in the discovery stage. The association signal was driven by two highly correlated SNPs with risk allele frequencies of 0.09.
Pale skin, poor tanning response, red or blonde hair, and blue or green eyes are known risk factors for CM and BCC. Gudbjartsson and colleagues used a candidate gene approach and genotyped 11 variants at eight loci, identified through GWAS for variants influencing hair, eye and skin pigmentation 5, 6 , in three case-control studies of CM from Iceland, Sweden and Spain, and two case-control studies of BCC from Iceland and Sweden. They also typed nine variants of MC1R already known to be associated with hair color and risk of both CM and BCC. A two-SNP haplotype at the ASIP locus (at 20q11) was most strongly associated with both CM and BCC, a coding variant in TYR also associated with both diseases, and TYRP1 was associated with CM but 
RHC, red hair color variants; NRHC; nonred hair color variants. Number of plus signs (+) indicates strength of evidence for association.
n e w s a n d v i e w s not BCC. The MC1R variants studies were only associated with CM in the Swedish and Spanish studies, but not the Icelandic study. This difference was not apparent when the analysis was restricted to invasive disease. The difference in risk may be due to population differences in interacting risk factors, but such differences between the Swedish and Icelandic populations seem unlikely. Alternatively, it may be due to differences in criteria for defining in situ disease, or to chance. Based on the Icelandic data, the risk estimates were not substantially attenuated by adjusting for hair, eye and skin pigmentation phenotypes. Indeed, the associations for the ASIP and TYR loci were stronger in individuals who were less sun-sensitive, a trend that has been previously observed for MC1R variants.
From marker to causal variant
Neither study carried out detailed fine mapping, and the associated SNPs and haplotypes should only be regarded as markers for a putative causal variant. Moving from marker to causal variant is a difficult exercise, and the initial step would be to resequence the region in a sample size sufficiently large to identify all the variants correlated with the associated markers. The fine mapping carried out by Brown and colleagues was limited to an evaluation of HapMap SNPs, and it is conceivable that many unidentified variants lie in the region. This is particularly relevant for the association with ASIP reported by Gudbjartsson and colleagues. The two-SNP haplotype is highly correlated with the two associated SNPs reported by Brown and colleagues, and it is highly likely that they are reporting on the same signal. However, the causal variant may be acting through one of several genes in the region, and it is premature to assume that ASIP is the culprit. The high gene density and extended linkage equilibrium in this region provides an excellent example of the potential hazard in assigning a risk allele to a gene-disease association in the absence of definitive functional evidence.
Clinical relevance
The disease risks associated with the alleles at the three loci are modest, and their ability to discriminate between those who will develop CM and those who will not is limited. Even in combination, their discriminatory ability will be small, and thus, their clinical utility will also be small. It is evident that the identification of these risk alleles is but a small part of a very complex puzzle. Epithelial pigmentation and sun-sensitivity are complex and related phenotypes, and it is likely that they interact with UV exposure in a complex way to lead to risk of CM and BCC. Some of that complexity is illustrated in Table 1 , which shows the associations between the SNPs reported here and a variety of pigmentation phenotypes. Furthermore, the pigmentation and sun-sensitivity phenotypes are also likely to affect UV exposurerelated behaviors. Hopefully, the success of these first generation GWAS will encourage new, larger genetic association studies with more detailed epithelial pigmentation and skin sensitivity phenotyping combined with more detailed lifetime UV exposure data. Such studies will help unravel the complex relationship between genotype, exposure and disease phenotype, which may in turn enable public health campaigns aimed to encourage sun avoidance behavior to be targeted at those most likely to benefit. In addition, and perhaps more importantly, a better understanding of the underlying biology may lead to improvements in disease management. volume 40 | number 7 | july 2008 | nature genetics
The intestinal epithelium, the layer of cells coating the surface of the intestinal lumen, performs vital tasks such as the processing and absorption of ingested micronutrients and the release of non-assimilated materials. While executing these functions, intestinal epithelial cells face constant insults, including exposure to digestive enzymes and bile acids and constant mechanical erosion by intestinal contents. Maintaining the functionality of the tissue in this extremely harsh environment represents a phenomenal challenge. Evolution has thus procured an effective mechanism to ensure integrity of intestinal function throughout life: fast and incessant regeneration of the epithelial sheet. Cell renewal is orchestrated through continuous cell migration starting in the crypts at the base of the epithelium and continuing toward the luminal surface (Fig. 1) . Each crypt behaves as a factory for cell production by hosting and nurturing the proliferation of hundreds of progenitor cells. The system is ultimately powered by a small number of long-lived multipotent cells, the intestinal stem cells (ISCs). Reporting on page 915 of this issue, Eugenio Sangiorgi and Mario Capecchi 1 use lineage tracing and cell ablation studies in mice to identify the Polycomb group protein Bmi1 as a specific marker of an ISC population located at the +4 position of the crypt. Their work reopens the discussion about the existence of this controversial cell population and provides a molecular entry point for studying its biology.
In search of ISCs
ISCs have remained elusive over the years because of lack of specific markers to distinguish them from other progenitor cells in the crypts, such that it was only possible to infer their localization by indirect means. Original work by Chris Potten and colleagues 2, 3 showed that DNA-labeling reagents, such 
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The tremendous regenerative power of the intestinal epithelium has attracted considerable attention to the crypt as a model for adult stem cell biology. a new study now identifies the Polycomb group protein Bmi1 as a specific marker of intestinal stem cells in vivo.
